157 related articles for article (PubMed ID: 24191941)
1. Editorial: Fc receptor-mediated effector functions in the humoral control of HIV-1 infection.
DeVico A
Curr HIV Res; 2013 Jul; 11(5):343-4. PubMed ID: 24191941
[No Abstract] [Full Text] [Related]
2. Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles.
Brown EP; Dowell KG; Boesch AW; Normandin E; Mahan AE; Chu T; Barouch DH; Bailey-Kellogg C; Alter G; Ackerman ME
J Immunol Methods; 2017 Apr; 443():33-44. PubMed ID: 28163018
[TBL] [Abstract][Full Text] [Related]
3. Opportunities to exploit non-neutralizing HIV-specific antibody activity.
Ackerman ME; Alter G
Curr HIV Res; 2013 Jul; 11(5):365-77. PubMed ID: 24191934
[TBL] [Abstract][Full Text] [Related]
4. Update on Fc-Mediated Antibody Functions Against HIV-1 Beyond Neutralization.
Su B; Dispinseri S; Iannone V; Zhang T; Wu H; Carapito R; Bahram S; Scarlatti G; Moog C
Front Immunol; 2019; 10():2968. PubMed ID: 31921207
[TBL] [Abstract][Full Text] [Related]
5. Qualitative and quantitative variables that affect the potency of Fc- mediated effector function in vitro and in vivo: considerations for passive immunization using non-neutralizing antibodies.
Lewis GK
Curr HIV Res; 2013 Jul; 11(5):354-64. PubMed ID: 24191940
[TBL] [Abstract][Full Text] [Related]
6. Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies.
Parsons MS; Chung AW; Kent SJ
Retrovirology; 2018 Aug; 15(1):58. PubMed ID: 30134945
[TBL] [Abstract][Full Text] [Related]
7. Vaccine-induced IgG2 anti-HIV p24 is associated with control of HIV in patients with a 'high-affinity' FcgammaRIIa genotype.
French MA; Tanaskovic S; Law MG; Lim A; Fernandez S; Ward LD; Kelleher AD; Emery S
AIDS; 2010 Aug; 24(13):1983-90. PubMed ID: 20634666
[TBL] [Abstract][Full Text] [Related]
8. Vaccines and immunology. Recent advances in HIV/AIDS vaccine development.
Landay A; Heeney JL
AIDS; 2001; 15 Suppl 5():S101-3. PubMed ID: 11816157
[No Abstract] [Full Text] [Related]
9. Introduction: HIV neutralizing antibodies: relevance to pathogenesis and vaccines.
Albert J; Chiodi F; Fenyö EM
J Intern Med; 2007 Jul; 262(1):2-4. PubMed ID: 17598811
[No Abstract] [Full Text] [Related]
10. HIV/AIDS: allied responses.
Mascola JR
Nature; 2007 Sep; 449(7158):29-30. PubMed ID: 17805280
[No Abstract] [Full Text] [Related]
11. New insights into protective humoral responses and HIV vaccines.
Stamatatos L; Davis D
AIDS; 2001; 15 Suppl 5():S105-15. PubMed ID: 11816158
[No Abstract] [Full Text] [Related]
12. Anti-retroviral antibody FcγR-mediated effector functions.
Bournazos S; Ravetch JV
Immunol Rev; 2017 Jan; 275(1):285-295. PubMed ID: 28133801
[TBL] [Abstract][Full Text] [Related]
13. HIV Vaccines: One Step Closer.
Low MSY; Tarlinton D
Trends Mol Med; 2017 Jan; 23(1):1-3. PubMed ID: 27889424
[TBL] [Abstract][Full Text] [Related]
14. Fc receptor-mediated immune responses: new tools but increased complexity in HIV prevention.
Vargas-Inchaustegui DA; Robert-Guroff M
Curr HIV Res; 2013 Jul; 11(5):407-20. PubMed ID: 24191937
[TBL] [Abstract][Full Text] [Related]
15. HIV vaccine development--improving on natural immunity.
Johnston MI; Fauci AS
N Engl J Med; 2011 Sep; 365(10):873-5. PubMed ID: 21899447
[No Abstract] [Full Text] [Related]
16. Fc receptor-mediated phagocytosis in tissues as a potent mechanism for preventive and therapeutic HIV vaccine strategies.
Sips M; Krykbaeva M; Diefenbach TJ; Ghebremichael M; Bowman BA; Dugast AS; Boesch AW; Streeck H; Kwon DS; Ackerman ME; Suscovich TJ; Brouckaert P; Schacker TW; Alter G
Mucosal Immunol; 2016 Nov; 9(6):1584-1595. PubMed ID: 26883728
[TBL] [Abstract][Full Text] [Related]
17. Role of Fc-mediated antibody function in protective immunity against HIV-1.
Lewis GK
Immunology; 2014 May; 142(1):46-57. PubMed ID: 24843871
[TBL] [Abstract][Full Text] [Related]
18. Diverse antiviral IgG effector activities are predicted by unique biophysical antibody features.
Cheng HD; Dowell KG; Bailey-Kellogg C; Goods BA; Love JC; Ferrari G; Alter G; Gach J; Forthal DN; Lewis GK; Greene K; Gao H; Montefiori DC; Ackerman ME
Retrovirology; 2021 Oct; 18(1):35. PubMed ID: 34717659
[TBL] [Abstract][Full Text] [Related]
19. Diversity of Antiviral IgG Effector Activities Observed in HIV-Infected and Vaccinated Subjects.
Huang Y; Ferrari G; Alter G; Forthal DN; Kappes JC; Lewis GK; Love JC; Borate B; Harris L; Greene K; Gao H; Phan TB; Landucci G; Goods BA; Dowell KG; Cheng HD; Bailey-Kellogg C; Montefiori DC; Ackerman ME
J Immunol; 2016 Dec; 197(12):4603-4612. PubMed ID: 27913647
[TBL] [Abstract][Full Text] [Related]
20. Antibody Functional Assays as Measures of Fc Receptor-Mediated Immunity to HIV - New Technologies and their Impact on the HIV Vaccine Field.
Wines BD; Billings H; Mclean MR; Kent SJ; Hogarth PM
Curr HIV Res; 2017; 15(3):202-215. PubMed ID: 28322167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
